With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...

Novo Nordisk faces headwinds from regulatory uncertainty, competitive efficacy gaps with Eli Lilly and technical downward ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

This article was reviewed by Lynn Marie Morski, MD, JD. How Long Does Ozempic® Stay in Your System? Key takeaways: Ozempic® ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...

Rybelsus is now FDA-approved for managing cardiovascular health. Doctors say oral GLP-1s may reduce heart attack and stroke ...

Doctors warn that weight-loss supplements can interact with other medications and may not be tested or standardized, so ...

At this month’s Food and Nutrition Conference and Expo in Nashville, one buzzword dominated conversations – GLP-1 medications ...

America's obesity epidemic costs an estimated $173 billion each year. The benefits of covering GLP-1s vastly outweigh the ...

This article was reviewed by Lynn Marie Morski, MD, JD. Ozempic Stomach Paralysis: Risks & Treatments Key takeaways: Stomach ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.